Abstract:Abstract Background and Aims Chronic kidney disease (CKD) is characterized with progressive fibrosis caused by excessive extracellular matrix (ECM) deposition. Tubular epithelial cells secreted increasing exosomes into extracellular space under pathological conditions with integrin as the prominent constituent membrane cargo. Due to the critical role of integrin in activation of TGF-β1 signalling, this study aims to investigate the performance of tubular-derived exosomes in the ECM microenvironment, exploring the potential mechanism of exosomal integrin mediated activation of latent TGF-β1. Method A fibrosis mouse model was established with unilateral ureteral obstruction (UUO) and an ITGβ6 overexpression cell line were established to observe the effect of ITGβ6+exosomes in vitro. Elastic or stress-relaxing hydrogels based on Polymethyl Methacrylate (PMMA) and acrylic acid-WGG(KA)3-heparin were constructed to mimic the in situ ECM under normal and fibrotic conditions with different stiffness (2kPa, 50kPa). Exosomes in hydrogels were tracked by single particle tracking to investigate their mobility and retention capability. Purified exosomal integrin β6 and inhibitor of exosome secretion, GW4869 was applied to clarify the role of exosomal integrin in latent TGF-β1 activation. Results In UUO model, immunofluorescence staining showed that latent TGF-β1 localized to ECM space and stored in the renal tubular interstitial which was activated with fibrotic progression. Additionally, we observed integrin β6 expression in tubule or interstitial increased with fibrotic progression. Isolated exosomes derived from cultured tubule cells under serum-free condition or renal tissues of UUO mice showed higher proportion of integrin β6+ subpopulation, as demonstrated via single exosome analysis by Nanoimaging (Oxford) . Interestingly, these exosomes diffused through hydrogels, while maintaining their original morphology and particle size. It turned out that stress-relaxing hydrogels with lower stiffness exhibited better retention of exosomes. Then, transwell experiment and single-particle tracking both revealed increased exosome diffusion rate in ECM with higher stiffness. Due to the critical role of integrin in the activation of latent TGFβ, we propose integrin β6+ exosome may exert such effect in ECM microenvironment. Impressively, purified ITGB6+ exosomes significantly increased TGF-β1 activation in TGF-β1 overexpressed HK-2 cells, while inhibiting exosome secretion via GW4869 treatment reversed such activation remarkably. Conclusion We demonstrated that tubular epithelial cell derived exosomal integrin β6 diffused in ECM space and promoted the activation of latent TGF-β1. Higher ECM stiffness correlates with accelerated movement of exosome which enhanced TGFβ1 activation. Exosomal integrin β6 may represent a novel manner of TGF-β1 activation with signal-spreading potential which may become a new therapeutic target for suppression of TGF-β1 activation in CKD treatment.

Unveiling the role of transgelin as a prognostic and therapeutic target in kidney fibrosis via a proteomic approach

Single-cell transcriptomic profiling of kidney fibrosis identifies a novel specific fibroblast marker and putative disease target

Single-cell sequencing dissects the transcriptional identity of activated fibroblasts and identifies novel persistent distal tubular injury patterns in kidney fibrosis

Dynamic multi-omics and mechanistic modeling approach uncovers novel mechanisms of kidney fibrosis progression

Transgelin-2 As an Early Detection for Diabetic Nephropathy Through Inflammation, Periostin and E-cadherin by STAT3 Signaling Through ANXA2.

EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis

Kidney Fibrosis: from Mechanisms to Therapeutic Medicines

#894 Dynamic multi-omics and mechanistic modelling approach provides deeper insight into kidney fibrosis progression

A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.

Transient Receptor Potential Channel 6 Knockout Ameliorates Kidney Fibrosis by Inhibition of Epithelial–Mesenchymal Transition

Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities

Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease

Phosphoproteomic Study of Human Tubular Epithelial Cell in Response to Transforming Growth Factor-Beta-1-induced Epithelial-to-mesenchymal Transition.

Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1

Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis

Renal Gene and Protein Expression Signatures for Prediction of Kidney Disease Progression

Single-cell transcriptomic profiling reveals decreased ER protein Reticulon3 drives the progression of renal fibrosis

#2376 Tubular exosomes in renal ECM microenvironment promotes fibrosis progression by activating latent TGF-β1

Role of Connective Tissue Growth Factor in Renal Tubular Epithelial-Myofibroblast Transdifferentiation and Extracellular Matrix Accumulation in Vitro.

Mechanism of transforming growth factor- β 1 induce renal fibrosis based on transcriptome sequencing analysis

Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification